CPH
Physician Daily · Monday, August 24, 2026
Newsletters Sign in ON AIR
CrosspointHealthNEWS + REFERENCE LIBRARY
Diagnosis Sheet Feeding and Eating Disorders DSM-5-TR 307.1 | ICD-10-CM F50.01, F50.02

Anorexia Nervosa

Energy restriction producing significantly low weight, driven by intense fear of weight gain and disturbed body image.

Lifetime prevalence~0.8-1.7% (women)
Typical onsetAges 14-20; bimodal peaks
Sex ratio~10:1 female:male
MortalitySMR ~5-6; ~5% per decade

Clinical picture

  • Presents emaciated yet describing the self as fat; family usually initiates the visit while the patient denies illness and negotiates every gram.
  • Rigid food rules, calorie counting, ritualized eating, cutting food into tiny pieces, and cooking elaborate meals for others without eating.
  • Compulsive exercise, standing rather than sitting, layered clothing that hides weight loss and blunts cold intolerance, and repeated body checking.
  • Exam shows bradycardia, hypotension, orthostasis, lanugo, dry skin, alopecia, cold mottled extremities, and amenorrhea or loss of libido.
  • Starvation-driven cognitive narrowing, irritability, social withdrawal, insomnia and food preoccupation mimic depression and obsessive-compulsive disorder.
  • Binge-purge subtype adds self-induced vomiting, laxative or diuretic misuse, parotid swelling, dental erosion and Russell sign on the knuckles.

Criteria snapshot

  • Three-part structure: energy restriction producing significantly low weight for age, sex and trajectory, plus fear of weight gain and body image disturbance.
  • Fear of fatness may be shown behaviorally as persistent interference with weight gain rather than voiced verbally, which is common in children.
  • Subtypes are assigned over the last 3 months as restricting or binge-eating/purging, and crossover between subtypes is common across the illness course.
  • Adult severity is anchored to BMI: mild at 17 or above, moderate 16 to 16.99, severe 15 to 15.99, extreme below 15; children use BMI percentile.
  • Amenorrhea was dropped as a criterion in DSM-5, and partial versus full remission specifiers track weight restoration separately from cognitive symptoms.

Neurobiology

  • Twin heritability is roughly 50-60%; a 2019 genome-wide study found eight risk loci plus metabolic correlations, reframing AN as metabo-psychiatric.
  • Altered insula and anterior cingulate processing distorts interoception and taste reward, while dorsal striatal habit circuitry sustains restriction.
  • Elevated 5-HT1A and reduced 5-HT2A binding with high CSF 5-HIAA after weight restoration suggests a trait anxious serotonergic system.
  • Starvation raises cortisol and ghrelin while lowering leptin, triiodothyronine and gonadotropins, producing functional hypothalamic amenorrhea.
  • Medical sequelae include sinus bradycardia, prolonged QTc, hypokalemia, osteopenia in over half of patients, and pseudoatrophy on brain MRI.
  • Refeeding syndrome from intracellular phosphate shift causes hypophosphatemia, hypokalemia and hypomagnesemia with cardiac failure in the first week.

Psychology

  • Weight and shape become the dominant basis of self-worth, and restriction delivers immediate relief and a sense of control that negatively reinforces it.
  • Premorbid perfectionism, harm avoidance, cognitive rigidity and weak central coherence persist after recovery and predict poorer long-term outcome.
  • The ego-syntonic quality means the disorder is experienced as identity and achievement, which flattens motivation and drives treatment ambivalence.
  • Family accommodation, high expressed emotion and criticism around meals maintain the illness, and FBT deliberately targets this interpersonal loop.
  • Alexithymia and social anxiety limit affect tolerance, so restriction functions as an emotion regulation strategy rather than as a diet.

Differential & comorbidity

  • Rule out malignancy, inflammatory bowel disease, celiac disease, hyperthyroidism, type 1 diabetes and adrenal insufficiency before attributing weight loss to AN.
  • Distinguish from ARFID, which lacks body image disturbance, from bulimia nervosa at normal weight, and from body dysmorphic disorder with non-weight focus.
  • Comorbidity is the rule: anxiety disorders in up to 65%, major depression near 40%, OCD in 15-20%, and substance use mainly in the binge-purge subtype.
  • Crude mortality is about 5% per decade with a standardized mortality ratio near 5-6, the highest in psychiatry, and roughly one in five deaths is suicide.
  • Obtain electrolytes, phosphate, ECG for QTc, and bone density after 6-12 months of amenorrhea; screen for insulin omission in type 1 diabetes.

Pharmacologic treatment

  • No medication carries FDA approval for anorexia nervosa; nutritional rehabilitation and weight restoration remain the primary, non-negotiable intervention.
  • Olanzapine 2.5-10 mg/day modestly improves weight gain in adults without changing obsessional thinking; monitor metabolic panel, QTc and sedation.
  • Fluoxetine 20-60 mg/day does not prevent relapse in underweight patients, so reserve SSRIs for comorbid depression or OCD after weight restoration.
  • Avoid bupropion because of seizure risk with purging, and use caution with any QTc-prolonging agent given bradycardia and electrolyte derangement.
  • Supplement vitamin D and calcium, check thiamine and phosphate before refeeding, and reserve bisphosphonates for selected adults rather than adolescents.

Psychotherapy

  • Family-based treatment is first-line for adolescents, delivering about 20 sessions over 12 months with roughly 40-50% full remission at one year.
  • CBT-E runs 20 sessions over 20 weeks for non-underweight patients and extends to 40 sessions over 40 weeks when BMI falls below 17.5.
  • MANTRA and specialist supportive clinical management are NICE-endorsed adult options with comparable outcomes; adult effects remain modest overall.
  • Weekly open weighing, structured meal planning and behavioral contracting anchor treatment, while motivational work supports but never replaces refeeding.
  • Adolescent-focused individual therapy is a reasonable alternative when family treatment is contraindicated by abuse or severe parental psychopathology.

Adjunct options

  • Escalate level of care on vital signs: heart rate below 50, systolic BP below 90, temperature below 36 C, or weight below 75% of expected body weight.
  • Contemporary inpatient refeeding starts higher at roughly 1500-2000 kcal/day with daily phosphate, potassium and magnesium checks for 5-7 days.
  • Partial hospitalization and intensive outpatient programs with supervised meals bridge the step-down and lower relapse rates after discharge.
  • Track progress with the EDE-Q, EAT-26 screening, growth charts, DEXA and serial ECG rather than relying on patient self-report of intake.
  • Coordinate care with a dietitian, pediatrician or internist, school personnel, and dentistry for enamel erosion in purging subtype patients.

Clinical pearls

  • Weight restoration precedes cognitive recovery; do not judge therapy failure in a starved brain.
  • Check phosphate daily for the first refeeding week: hypophosphatemia kills, not the calories.
  • Highest mortality of any psychiatric illness, and one in five deaths is suicide, not starvation.

References

  • American Psychiatric Association. (2022). Diagnostic and statistical manual of mental disorders (5th ed., text rev.). https://doi.org/10.1176/appi.books.9780890425787
  • Arcelus, J., Mitchell, A. J., Wales, J., & Nielsen, S. (2011). Mortality rates in patients with anorexia nervosa and other eating disorders: A meta-analysis of 36 studies. Archives of General Psychiatry, 68(7), 724-731. https://doi.org/10.1001/archgenpsychiatry.2011.74
  • Lock, J., Le Grange, D., Agras, W. S., Moye, A., Bryson, S. W., & Jo, B. (2010). Randomized clinical trial comparing family-based treatment with adolescent-focused individual therapy for adolescents with anorexia nervosa. Archives of General Psychiatry, 67(10), 1025-1032. https://doi.org/10.1001/archgenpsychiatry.2010.128
  • National Institute for Health and Care Excellence. (2017). Eating disorders: Recognition and treatment (NICE Guideline NG69). https://www.nice.org.uk/guidance/ng69
  • National Institute of Mental Health. (n.d.). Eating disorders. U.S. Department of Health and Human Services. https://www.nimh.nih.gov/health/topics/eating-disorders
  • Sadock, B. J., Sadock, V. A., & Ruiz, P. (2021). Kaplan & Sadock's synopsis of psychiatry (12th ed.). Wolters Kluwer.
  • Stahl, S. M. (2021). Stahl's essential psychopharmacology (5th ed.). Cambridge University Press.